ArticleThe New England journal of medicine2018
Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
Article in The New England journal of medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.Drug and alcohol dependence · 2024Observational
- What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada.Substance abuse treatment, prevention, and policy · 2024Article
- Increasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.Frontiers in medicine · 2024Article
- Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology.American journal of clinical dermatology · 2023Article
- National trends in buprenorphine prescribing before and during the COVID-19 pandemic.Journal of substance abuse treatment · 2023Article
- Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice.Substance abuse · 2022Review
- Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.JAMA health forum · 2022Article
- Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.BMC health services research · 2022Article
- The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.Substance abuse and rehabilitation · 2022Review
- Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.Drug and alcohol dependence · 2021Article
- Changes in Buprenorphine Treatment After Medicaid Expansion.Psychiatric services (Washington, D.C.) · 2021Article
- Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder.Medical care · 2021Article
- Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder.JAMA network open · 2021Article
- Article
- A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.Substance abuse treatment, prevention, and policy · 2020Article
- Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.Health affairs (Project Hope) · 2020Article
- Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?The International journal on drug policy · 2020Article
- The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.Journal of substance abuse treatment · 2020Article
- Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.Addiction science & clinical practice · 2019Article
- Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?Addiction (Abingdon, England) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.